Disclosure Statement of Financial Interest

Slides:



Advertisements
Similar presentations
TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
Advertisements

Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
PCI in Left Main Coronary Bifurcation Disease -Step Mini Crush
Universitatea de Medicina si Farmacia Targu Mures Spitalul Judetean de Urgenta Clinica de Cardiologie Prof. Dr. Benedek Imre, FESC Universitatea de Medicina.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis.
CIT 2016 Template Title 40 pt Bold Arial David Liu, MD Subtitle 34 pt Arial Bold Italics.
Dedicated Bifurcation Stent Technology: Implications for Everyday Practice Jens Flensted Lassen MD, PH.D., FESC The Heart Centre, Rigshospitalet University.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Lessons from PARTNER I (A & B) CRT, Washington DC, Feb 5, 2012
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Revascularization Strategy: Syntax Score and Beyond
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Abdominal Aortic Aneurysm Repair Hugo Londero Sanatorio Allende Córdoba - Argentina.
De Novo and Restenotic Coronary Lesions
Disclosure Statement of Financial Interest
High Definition (HD) IVUS: A New Approach to Improve Conventional IVUS
Valvuloplasty Scoring Balloon for the Treatment of Critical Aortic Valve Stenosis - Design of a FIM Study - Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC.
Disclosure Statement of Financial Interest
Ajay J. Kirtane, MD I have no real or apparent conflicts of interest to report.
Blood supply of the Heart & Conduction System
Debate: Prophylactic Support Increases Risk With Little Benefit
IVUS, FFR, OCT- Which Should I Use For PCI?
Physiologic Lesion Assessment: Advantages and Pitfalls
How to Build A Successful Clinical Research Program
Advanced CTO Techniques:
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
Non-Inferiority Exposed: Uses and Abuses
BRS Sizing and Vessel Preparation
Novel atherectomy devices for the coronary calcified lesions
(DES)+BVS +DCB for long diffuse LAD disease
On behalf of the PRECOMBAT Investigators
Washington Hospital Center, Division of Cardiology
Columbia University Medical Center Cardiovascular Research Foundation
Next Generation HD IVUS
Atherosclerosis and Erectile Dysfunction: Is PTA with DES the answer?
The Tryton Bifurcation Trial:
Craig A. Thompson, M.D., MMSc.
DKCRUSH V Shao-Liang Chen, MD DKCRUSH V
The DKCRUSH-V Randomized Trial
Comprehensive Meta-Analysis of DES vs
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Novolimus Elution from a Biodegradable Polymer Coated Coronary Stent
EXCELLA Studies - Novolimus Elution from PLLA Polymer Coated Stents DESyne® and DESyne BD: Design Specifications and Clinical Updates Stefan Verheye,
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
OCT-Guided PCI What needs to be done to establish criteria?
Collagenase for CTO: An update Bradley H
Thomas Stiermaier, MD; Suzanne de Waha, MD;
Three Years Follow Up. SORT OUT II
CIT 2018 Template Title 40 pt Bold Arial
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Left Main PCI: What is Best Practice?
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Five-Year Cumulative Rates of Clinical Events after Cypher™ Stent Implantation: Insights from a Patient-Level Pooled Analysis of Four Randomized Trials.
CIT 2018 Template Title 40 pt Bold Arial
TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES
CIT 2017 Template Title 40 pt Bold Arial
Intracoronary imaging to guide percutaneous coronary intervention: Clinical implications  Giancarla Scalone, Giampaolo Niccoli, Omar Gomez Monterrosas,
CIT 2017 Template Title 40 pt Bold Arial
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Division of Endovascular Interventions
Comprehensive Meta-Analysis of DES vs
CIT 2017 Template Title 40 pt Bold Arial
Gregg W. Stone, MD Columbia University Medical Center
Frequency-domain optical coherence tomography evaluation of a patient with Kawasaki disease and severely calcified plaque  Yusuke Fujino, Guilherme F.
Title 40pt Trebuchet MS Bold
CIT 2018 Template Title 40 pt Bold Arial
Presentation transcript:

Hungary Presents: Use of Imaging for Left Main PCI Optimization István F. Édes MD PhD Semmelweis University Heart and Vascular Center Budapest, Hungary edes789@gmail.com

Disclosure Statement of Financial Interest I, István F. Édes DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Left Main (LM) disease Significant LM disease significantly impacts coronary artery disease (CAD) prognosis LM revascularization is a difficult decision: LM size and disease severity Complexity of the LM lesion Concomitant CAD and other disease Clinical manifestation of LM stenoses

Left Main treatment LM treatment in most cases still remains a prime target for the surgeon PCI CABG LM Syntax score <22 I B LM Syntax score 23-32 IIa B 3VD, LM Syntax score 23-32 III B I A 3VD, LM Syntax score >32 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 3

Left Main treatment The more severe the issue the less PCI comes into question (Syntax Trial) But… Emergency cases (ACS) Third generation DES Single stent based prefered strategies Better patient selection Better DAPT (prasugel & ticagrelor) Availablity of routine intravascular imaging

Intracoronary imaging - guidelines ACC - 2011 Class IIa IVUS is reasonable for the assessment of angiographically indeterminant left main CAD. (Level of Evidence: B) IVUS is reasonable to determine the mechanism of stent restenosis (Level of Evidence: C) Class IIb – IVUS may be reasonable for the assessment of non–left main coronary arteries with angiographically intermediate coronary stenoses (50% to 70% diameter stenosis). (Level of Evidence: B) IVUS may be considered for guidance of coronary stent implantation, particularly in cases of left main coronary artery stenting. (Level of Evidence: B) IVUS may be reasonable to determine the mechanism of stent thrombosis (Level of Evidence: C) ESC - 2015 IVUS / OCT In case of stent restenosis and thrombosis– Class IIa, LoE: C LM PCI with IVUS initally grants better short term results IVUS guided PCI decreased stent thrombosis and restenosis rates

Invasive imaging pros and cons Intravasular Ultrasound 20-60 MHz frequency Ultrasound technique ~100-150 µm resolution 6-7 mm penetration Real-time imaging Calcification NURD Spasm Optical Cohoerence Tomography 300 nm range Light based technique ~10-15 µm resolution (cellular level) 2-3 mm penetration Penetration through calcification Non real-time Contrast flush need LM imaging Preferred modality: IVUS! 6

When and how to use IVUS in the LM? Recommendation LM PCI planned To assess severity: IVUS alone may not be optimal, as functional testing and/or ischaemia induction may be needed. But, aim for a target MLA: <6 mm2 Pre-PCI: Evaluate LM size, calcification, fibroelastic components, bifurcation (bi-directional IVUS) and ostial status. Post-PCI: Evaluate stent edges, apposition, need for post-dilation, bifurcation geometry. Determine pre-PCI IVUS characteristics IVUS no-cross Predilate Bifurcation disease Non-bif. disease IVUS again IVUS both ways Optimally prepare LM lesion IVUS both ways, optimize stent as needed Apply stents (one preferred)

Pre-PCI imaging: more tips&tricks Ostial lesion? Assess amount of calcium, fibrous tissue Shaft lesion? Carefully verify if bifurcation and ostium are truly unaffected Bifurcation lesion? Focus on the degree of bi-directional disease (plaque burden)

Post-PCI imaging: more tips&tricks Ostial stent? Assess prolapse of stent into the aorta, create a cone as needed Shaft stent only? Very carefully assess if bifurcation and ostium are truly uncovered Bifurcation stents? Concentrate on the neo-carina

Thank you for your attention!